Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 4
2006 1
2007 6
2008 6
2010 1
2015 1
2016 2
2017 2
2018 2
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Cytokeratin and CDX-2 expression in Barrett's esophagus.
van Baal JW, Bozikas A, Pronk R, Ten Kate FJ, Milano F, Rygiel AM, Rosmolen WD, Peppelenbosch MP, Bergman JJ, Krishnadath KK. van Baal JW, et al. Among authors: rosmolen wd. Scand J Gastroenterol. 2008;43(2):132-40. doi: 10.1080/00365520701676575. Scand J Gastroenterol. 2008. PMID: 18224560
Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study.
Timmer MR, Martinez P, Lau CT, Westra WM, Calpe S, Rygiel AM, Rosmolen WD, Meijer SL, Ten Kate FJ, Dijkgraaf MG, Mallant-Hent RC, Naber AH, van Oijen AH, Baak LC, Scholten P, Böhmer CJ, Fockens P, Maley CC, Graham TA, Bergman JJ, Krishnadath KK. Timmer MR, et al. Among authors: rosmolen wd. Gut. 2016 Oct;65(10):1602-10. doi: 10.1136/gutjnl-2015-309642. Epub 2015 Jun 23. Gut. 2016. PMID: 26104750 Free PMC article.
The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: results from a randomized controlled trial (SURF trial).
Phoa KN, Rosmolen WD, Weusten BLAM, Bisschops R, Schoon EJ, Das S, Ragunath K, Fullarton G, DiPietro M, Ravi N, Tijssen JGP, Dijkgraaf MGW, Bergman JJGHM; SURF investigators. Phoa KN, et al. Among authors: rosmolen wd. Gastrointest Endosc. 2017 Jul;86(1):120-129.e2. doi: 10.1016/j.gie.2016.12.001. Epub 2016 Dec 9. Gastrointest Endosc. 2017. PMID: 27956164 Clinical Trial.
23 results